Answers are grounded in this paper and cite their sources.
PURPOSE: Targeted radionuclide therapy can treat early-stage tumors and microscopic disease; however, accurate cellular and multicellular dosimetry remains challenging due to sub-resolution imaging. This study provides S-values (Gy/Bq) for 35 radionuclides in single cells and spherical clusters to improve microtumor dose and surviving fraction estimates and to guide effective radionuclide selection. MATERIALS AND METHODS: Radiation doses and S-values were calculated for 35 alpha-, beta-, and low-energy electron emitters using MIRDcell software. Models ranged from single cells to multicellular spherical clusters (up to 800 µm in diameter), with concentric nuclei and cytoplasm and assuming a uniform activity distribution. Calculations included self-dose and cross-fire dose. Radial dose distributions were used to determine Peripheral Dose Percentage, and surviving fractions were estimated via a linear-quadratic model considering LET, particle range, radiation type, and subcellular radionuclide localization. RESULTS: S-values decreased exponentially with cluster size. Alpha emitters delivered ∼213-fold higher dose per unit activity than low-energy electrons and ∼206-fold higher than beta emitters. Alpha and low-energy electron emitters produced highly localized, very high doses with minimal surviving fractions, whereas beta emitters showed spatially diffuse dose distributions and higher survival. Dose heterogeneity at the tumor periphery was influenced by cross-fire, particle range, and subcellular radionuclide localization. Therapeutic effectiveness followed radionuclide localization in nucleus, cytoplasm, and membrane and depended on LET, particle range, cluster geometry, and radionuclide distribution. CONCLUSION: Radionuclide selection, subcellular localization, and dose homogeneity-especially at the tumor periphery-are critical in targeted therapy. Alpha emitters provide highly localized cytotoxic doses, low-energy electrons offer strong subcellular selectivity, and beta emitters produce diffuse distributions with significant cross-fire. Absorbed dose and cell survival are governed by radiation type, particle range, LET, and micro- and subcellular radionuclide distribution, emphasizing that radiobiological effectiveness cannot be inferred from mean dose alone. These findings establish a quantitative framework for selecting radionuclides in precision nuclear medicine and microdosimetric treatment planning.
No takes yet. Share an insight, caveat, or question.
Willegaignon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: